A Trial Summary Can Be Accurate and Still Mislead
A trial summary can be technically accurate and still mislead. Check whether an AI summary preserved the population, effect size, and safety findings.
Who this is for
Healthcare and life sciences researchers — Medical writers, biotech researchers, and analysts who rely on AI to summarize clinical trial results before citing them
The problem
"Drug X significantly improved symptoms compared to placebo" can be a completely accurate sentence and still leave out everything that matters: how large the improvement actually was, which patients it was tested in, and what the dropout and adverse-event rates looked like in the treatment arm. Every individual word can be true while the overall impression the sentence creates is wrong.
AI summaries compress trial results in exactly this way — toward the topline finding and away from the population, effect size, and safety context that determine whether the topline finding actually matters for a given patient or claim.
How ConvergePanel helps
ConvergePanel checks an AI-generated trial summary against the source data across five models: does the summary preserve the population, the effect size, the confidence interval, and the safety findings — or does it compress them into a cleaner, less qualified statement. Where models disagree on whether a qualification was dropped, that's the exact line to check against the paper.
How they compare
| Source Statement | AI Summary | Missing Qualification | Omitted Safety Issue | Reviewer Correction |
|---|---|---|---|---|
| Symptom score improved by 2.1 points (p=0.03) vs. placebo over 12 weeks in patients with moderate-to-severe disease (n=340) | "Drug X significantly improved symptoms compared to placebo" | Drops the effect size, the population restriction, and the 12-week window — reads as a general, unqualified benefit | 18% dropout in the treatment arm vs. 9% in placebo not mentioned | Cite the absolute effect size, the studied population, and the dropout differential; separate statistical from clinical significance |
How it works
- 1Identify the trial's study design, population, and sample size from the methods section
- 2Check inclusion and exclusion criteria against how the summary describes the studied population
- 3Compare the primary and secondary endpoints to what the summary claims was measured
- 4Check the effect size and confidence interval, not just whether the result was statistically significant
- 5Confirm the summary distinguishes statistical significance from clinical significance
- 6Check adverse event rates, dropout rate, and subgroup findings against the summary
- 7Note funding source, conflicts of interest, and publication status
- 8Flag any summary claim that isn't supported by these specifics
Use cases
- Checking whether an AI trial summary preserved the study population and effect size
- Verifying that statistical significance wasn't presented as clinical significance
- Confirming adverse events and dropout rates weren't omitted from a summary
- Auditing an AI-generated literature summary before it's cited in a report or memo
Seventeen specifics a summary can quietly drop
- Study design — randomized, blinded, controlled, or open-label
- Population — who was actually studied
- Sample size — how many patients the result rests on
- Inclusion criteria — who qualified for the trial
- Exclusion criteria — who was deliberately left out
- Primary endpoint — the trial's actual pre-specified measure of success
- Secondary endpoint — supporting measures, not the trial's main test
- Effect size — the magnitude of the difference, not just its direction
- Confidence interval — the range of plausible true effect sizes
- Statistical significance — whether the result is unlikely to be chance
- Clinical significance — whether the effect size is large enough to matter to a patient
- Adverse events — what happened to safety, not just efficacy
- Dropout rate — who left the trial, and whether it differed by arm
- Subgroup findings — whether the effect held across different patient groups
- Limitations — what the authors themselves flagged as constraints
- Funding and conflicts — who paid for the trial
- Publication status — peer-reviewed, preprint, or conference abstract
Statistically significant is not the same claim as clinically significant
A large enough trial can find a statistically significant effect that's too small to matter to an actual patient — and a summary that reports only the p-value gives no way to tell the two apart. The effect size and confidence interval are what separate "detectable" from "meaningful," and they're exactly the numbers most likely to be dropped when a result gets compressed into a single sentence.
Frequently asked questions
What should be checked first in an AI-generated trial summary?
The population and the effect size. A summary that states direction ("improved," "reduced") without the magnitude or the studied population is the most common and most consequential compression to catch.
Why do primary and secondary endpoints matter if both showed improvement?
Because the trial was designed and powered to detect an effect on its primary endpoint — a secondary endpoint result is exploratory by comparison and carries a different evidentiary weight, even when both point the same direction.
Can an AI summary omit adverse events without saying anything false?
Yes. Omission isn't the same as fabrication — a summary can be word-for-word accurate about efficacy and simply not mention the safety data at all, which is exactly why safety findings need a dedicated check rather than an assumption they're covered.
Does statistical significance prove clinical importance?
No. A statistically significant result confirms the effect is unlikely to be due to chance in this dataset — it says nothing on its own about whether the effect size is large enough to matter for a patient's actual outcome.
How much does the dropout rate matter if the topline result was positive?
It can matter considerably, especially if dropout was higher in the treatment arm — that pattern can signal tolerability problems the topline efficacy number doesn't capture.
Can ConvergePanel determine whether a treatment is safe?
No. ConvergePanel supports evidence review and model comparison — checking whether an AI summary preserved a trial's population, effect size, and safety findings. It does not provide medical advice or determine clinical validity; that requires a qualified clinician or researcher.
Explore related pages
ConvergePanel provides AI-assisted verification for informational purposes only. Not forensic analysis. Not legal evidence.
More in How-To
How to Verify a Viral Claim with AI
How does AI claim verification actually work? Learn the mechanics: independent model queries, consensus scoring, and how to read disagreement as a research signal.
How to Review a Suspicious Video with AI
Use AI-assisted review to check suspicious videos for context, visual claims, manipulation risk, and source uncertainty.
How to Verify a Viral Claim Before You Share It
Viral claims travel six times faster than corrections. Check the source, date, and model disagreement in under two minutes before you share.